Abstract
Nicotine exposure in pregnant rats and sheep has shown a more than 50% increase in female fetal testosterone (FFT) levels. Increased testosterone levels have also been linked to infertility, increased anogenital distance (AGD), and reduced second to fourth digit (2D:4D) finger length ratios (FLR). In humans, we hypothesized that maternal total testosterone (MTT) levels would increase in smoking mothers and would cause increased FFT levels, increased AGD, and decreased 2D:4D FLR. This prospective study separated women expecting a female fetus into nonsmoking and smoking cohorts. Maternal cotinine (MC) was tested at 3rd trimester and delivery to assess nicotine exposure. MTT levels were drawn at delivery, and FFT levels were collected from cord blood. The AGD and 2D:4D FLRs were measured at birth. Data were analyzed using parametric and nonparametric tests. The data of 36 smokers and 28 nonsmokers were analyzed. Smoking mothers had higher parity, drug abuse history and were more likely white race. No statistical differences were seen among the primary outcomes of MTT and FFT. MTT was higher among nonsmokers versus smokers (144 versus 107 ng/dL). No correlations were noted between MC levels at delivery, MTT, and FFT levels. No statistical differences were noted among secondary outcomes of AGD and FLR. Although animal studies showed increased FFT levels after nicotine exposure, this was not seen in our human study. Placental differences in animals and humans may be at work. Our pilot study reveals a need for research on the effects of smoking in pregnancy on fetal hormones.
Similar content being viewed by others
Data Availability
Clinical trial ID: NCT02610751. Website: https://clinicaltrials.gov/ct2/show/NCT02610751.
Code Availability
Not applicable.
References
Smith LM, Cloak CC, Poland RE, Torday J, Ross MG. Prenatal nicotine increases testosterone levels in the fetus and female offspring Nicotine & tobacco research : official. J Soc Res Nicotine Tob. 2003;5:369–74.
Rizwan S, Manning JT, Brabin BJ. Maternal smoking during pregnancy and possible effects of in utero testosterone: evidence from the 2D:4D finger length ratio. Early Human Dev. 2007;83:87–90.
Matthews, TJ. Smoking during pregnancy. Centers for Disease Control and Prevention: Publications and Reports of the Surgeon General. 2010; 54–57. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5339a1.htm
Cornelius MD, Day NL. Developmental consequences of prenatal tobacco exposure. Curr Opin Neurol. 2009;22:121–5.
Cornelius MD, Leech SL, Goldschmidt L, Day NL. Is prenatal tobacco exposure a risk factor for early adolescent smoking? A follow-up study. Neurotoxicol Teratol. 2005;27:667–76.
Cornelius MD, Leech SL, Goldschmidt L, Day NL. Prenatal tobacco exposure: is it a risk factor for early tobacco experimentation? Nicotine & tobacco research : official journal of the. Soc Res Nicotine Tob. 2000;2:45–52.
James WH. Potential explanation of the reported association between maternal smoking and autism. Environ Health Perspect. 2013;121: a42.
Sebelius, K. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. Centers for Disease Control and Prevention: Publications and Reports of the Surgeon General. 2010:xv, 704. https://www.pubmed.ncbi.nlm.nih.gov/21452462/
Stroud LR, Papandonatos GD, Shenassa E, et al. Prenatal glucocorticoids and maternal smoking during pregnancy independently program adult nicotine dependence in daughters: a 40-year prospective study. Biol Psychiat. 2014;75:47–55.
Duskova M, Hruskovicova H, Simunkova K, Starka L, Parizek A. The effects of smoking on steroid metabolism and fetal programming. J Steroid Biochem Mol Biol. 2014;139:138–43.
Ernst A, Kristensen SL, Toft G, et al. Maternal smoking during pregnancy and reproductive health of daughters: a follow-up study spanning two decades. Hum Reprod. 2012;27:3593–600.
Thankamony A, Ong KK, Dunger DB, Acerini CL, Hughes IA. Anogenital distance from birth to 2 years: a population study. Environ Health Perspect. 2009;117:1786–90.
Benowitz NL, Jacob P 3rd, Fong I, Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther. 1994;268:296–303.
Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18:188–204.
Barbieri RL, York CM, Cherry ML, Ryan KJ. The effects of nicotine, cotinine and anabasine on rat adrenal 11 beta-hydroxylase and 21-hydroxylase. J Steroid Biochem. 1987;28:25–8.
Matta SG, Valentine JD, Sharp BM. Nicotinic activation of CRH neurons in extrahypothalamic regions of the rat brain. Endocrine. 1997;7:245–53.
James WH. An update on the hypothesis that one cause of autism is high intrauterine levels of testosterone of maternal origin. J Theor Biol. 2014;355:33–9.
Kandel DB, Udry JR. Prenatal effects of maternal smoking on daughters’ smoking: nicotine or testosterone exposure? Am J Public Health. 1999;89:1377–83.
Sheehan MT. Polycystic ovarian syndrome: diagnosis and management. Clin Med Res. 2004;2:13–27.
Keelan JA, Mattes E, Tan H, et al. Androgen concentrations in umbilical cord blood and their association with maternal, fetal and obstetric factors. PLoS ONE. 2012;7:e42827.
ARUP Laboratories. Accessed September 9, 2021. https://ltd.aruplab.com/
Ross KC, et al. Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking. Pharmacol Biochem Behav. 2016;148:1–7. https://doi.org/10.1016/j.pbb.2016.05.002.
Signorelloa LB, et al. Racial differences in serum cotinine levels of smokers. Dis Markers. 2009;27(5):187–92. https://doi.org/10.3233/DMA-2009-0661.
Acknowledgements
We would like to acknowledge the following people who had an integral role in helping us execute our study goals: thank you to the Medical Education Research Fund (MERF), who provided funding for the study. Thank you to the TriHealth Hatton Research Institute staff who helped in the screening, recruiting, enrollment, and data collection for our study. We would like to recognize the work of Vickie Glover, Carolyn Lindeman RN, Pam Plummer RN, and Kathyrn Waligura BA, BS. Thank you for your hard work.
Funding
Financial support was provided by Good Samaritan Hospital Medical Education Research Fund, this financial sponsor had no role in the study or decision to submit the study for publication.
Author information
Authors and Affiliations
Ethics declarations
Ethics Approval
The TriHealth Institutional Review Board (IRB) and Perinatal Scientific Review Committee (PSRC) approval was obtained prior to the initiation of the study.
Consent to Participate
Patients who agreed to be in the study signed informed consent prior to enrollment in the study.
Consent for Publication
This manuscript is submitted solely to The Reproductive Sciences Journal. No substantial part of this paper has been published elsewhere, except for a scientific abstract #F-095 presented as a virtual poster presentation at the Society for Reproductive Investigation’s 67th Annual Scientific Meeting, March 13, 2020, Vancouver, Canada. This publication has been approved by all co-authors. A transfer of copyright to the Society for Reproductive Investigation will be signed upon acceptance of publication.
Conflict of Interest
The authors declare no competing interests.
Additional information
Prospective cohort study comparing the female fetal testosterone levels of newborns of women who actively smoke tobacco in pregnancy and those who do not, results have shown no correlation between maternal smoking in pregnancy and maternal total testosterone levels or female fetal testosterone levels.
Rights and permissions
About this article
Cite this article
Gordon, S.S., Dhanraj, D.N., Ganga Devaiah, C. et al. A Pilot Study of Exposure to Nicotine in Human Pregnancy and Maternal and Fetal Testosterone Levels at Birth. Reprod. Sci. 29, 3254–3259 (2022). https://doi.org/10.1007/s43032-022-00967-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43032-022-00967-2